Extra-Virgin Olive Oil Enhances the Blood–Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial

Mild cognitive impairment (MCI) and early Alzheimer’s disease (AD) are characterized by blood–brain barrier (BBB) breakdown leading to abnormal BBB permeability ahead of brain atrophy or dementia. Previous findings in AD mouse models have reported the beneficial effect of extra-virgin olive oil (EVO...

Full description

Bibliographic Details
Main Authors: Amal Kaddoumi, Thomas S. Denney, Gopikrishna Deshpande, Jennifer L. Robinson, Ronald J. Beyers, David T. Redden, Domenico Praticò, Tassos C. Kyriakides, Bonian Lu, Anna N. Kirby, Darren T. Beck, Nancy D. Merner
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/14/23/5102
_version_ 1797462453811937280
author Amal Kaddoumi
Thomas S. Denney
Gopikrishna Deshpande
Jennifer L. Robinson
Ronald J. Beyers
David T. Redden
Domenico Praticò
Tassos C. Kyriakides
Bonian Lu
Anna N. Kirby
Darren T. Beck
Nancy D. Merner
author_facet Amal Kaddoumi
Thomas S. Denney
Gopikrishna Deshpande
Jennifer L. Robinson
Ronald J. Beyers
David T. Redden
Domenico Praticò
Tassos C. Kyriakides
Bonian Lu
Anna N. Kirby
Darren T. Beck
Nancy D. Merner
author_sort Amal Kaddoumi
collection DOAJ
description Mild cognitive impairment (MCI) and early Alzheimer’s disease (AD) are characterized by blood–brain barrier (BBB) breakdown leading to abnormal BBB permeability ahead of brain atrophy or dementia. Previous findings in AD mouse models have reported the beneficial effect of extra-virgin olive oil (EVOO) against AD, which improved BBB and memory functions and reduced brain amyloid-β (Aβ) and related pathology. This work aimed to translate these preclinical findings to humans in individuals with MCI. We examined the effect of daily consumption of refined olive oil (ROO) and EVOO for 6 months in MCI subjects on BBB permeability (assessed by contrast-enhanced MRI), and brain function (assessed using functional-MRI) as the primary outcomes. Cognitive function and AD blood biomarkers were also assessed as the secondary outcomes. Twenty-six participants with MCI were randomized with 25 participants completed the study. EVOO significantly improved clinical dementia rating (CDR) and behavioral scores. EVOO also reduced BBB permeability and enhanced functional connectivity. While ROO consumption did not alter BBB permeability or brain connectivity, it improved CDR scores and increased functional brain activation to a memory task in cortical regions involved in perception and cognition. Moreover, EVOO and ROO significantly reduced blood Aβ<sub>42</sub>/Aβ<sub>40</sub> and p-tau/t-tau ratios, suggesting that both altered the processing and clearance of Aβ. In conclusion, EVOO and ROO improved CDR and behavioral scores; only EVOO enhanced brain connectivity and reduced BBB permeability, suggesting EVOO biophenols contributed to such an effect. This proof-of-concept study justifies further clinical trials to assess olive oil’s protective effects against AD and its potential role in preventing MCI conversion to AD and related dementias.
first_indexed 2024-03-09T17:36:50Z
format Article
id doaj.art-6577c2e7e3b34fbdb513df2fafe488d9
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-09T17:36:50Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-6577c2e7e3b34fbdb513df2fafe488d92023-11-24T11:52:15ZengMDPI AGNutrients2072-66432022-12-011423510210.3390/nu14235102Extra-Virgin Olive Oil Enhances the Blood–Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled TrialAmal Kaddoumi0Thomas S. Denney1Gopikrishna Deshpande2Jennifer L. Robinson3Ronald J. Beyers4David T. Redden5Domenico Praticò6Tassos C. Kyriakides7Bonian Lu8Anna N. Kirby9Darren T. Beck10Nancy D. Merner11Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USACenter for Neuroscience, Auburn University, Auburn, AL 36849, USACenter for Neuroscience, Auburn University, Auburn, AL 36849, USACenter for Neuroscience, Auburn University, Auburn, AL 36849, USAAuburn University MRI Research Center, Department of Electrical & Computer Engineering, Auburn University, Auburn, AL 36849, USABiomedical Affairs and Research, Edward Via College of Osteopathic Medicine, Auburn University, Auburn, AL 36849, USAAlzheimer’s Center at Temple, Lewis Katz School of Medicine Temple University, Philadelphia, PA 19140, USAYale School of Public Health, New Haven, CT 06510, USAAuburn University MRI Research Center, Department of Electrical & Computer Engineering, Auburn University, Auburn, AL 36849, USADepartment of Cell Biology and Physiology and Preventive Medicine and Public Health, Edward Via College of Osteopathic Medicine, Auburn University, Auburn, AL 36849, USADepartment of Cell Biology and Physiology, Via College of Osteopathic Medicine, Auburn University, Auburn, AL 36849, USADepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USAMild cognitive impairment (MCI) and early Alzheimer’s disease (AD) are characterized by blood–brain barrier (BBB) breakdown leading to abnormal BBB permeability ahead of brain atrophy or dementia. Previous findings in AD mouse models have reported the beneficial effect of extra-virgin olive oil (EVOO) against AD, which improved BBB and memory functions and reduced brain amyloid-β (Aβ) and related pathology. This work aimed to translate these preclinical findings to humans in individuals with MCI. We examined the effect of daily consumption of refined olive oil (ROO) and EVOO for 6 months in MCI subjects on BBB permeability (assessed by contrast-enhanced MRI), and brain function (assessed using functional-MRI) as the primary outcomes. Cognitive function and AD blood biomarkers were also assessed as the secondary outcomes. Twenty-six participants with MCI were randomized with 25 participants completed the study. EVOO significantly improved clinical dementia rating (CDR) and behavioral scores. EVOO also reduced BBB permeability and enhanced functional connectivity. While ROO consumption did not alter BBB permeability or brain connectivity, it improved CDR scores and increased functional brain activation to a memory task in cortical regions involved in perception and cognition. Moreover, EVOO and ROO significantly reduced blood Aβ<sub>42</sub>/Aβ<sub>40</sub> and p-tau/t-tau ratios, suggesting that both altered the processing and clearance of Aβ. In conclusion, EVOO and ROO improved CDR and behavioral scores; only EVOO enhanced brain connectivity and reduced BBB permeability, suggesting EVOO biophenols contributed to such an effect. This proof-of-concept study justifies further clinical trials to assess olive oil’s protective effects against AD and its potential role in preventing MCI conversion to AD and related dementias.https://www.mdpi.com/2072-6643/14/23/5102Alzheimer’s diseasemild cognitive impairmentblood–brain barriercontrast-enhanced MRIfunctional MRIextra-virgin olive oil
spellingShingle Amal Kaddoumi
Thomas S. Denney
Gopikrishna Deshpande
Jennifer L. Robinson
Ronald J. Beyers
David T. Redden
Domenico Praticò
Tassos C. Kyriakides
Bonian Lu
Anna N. Kirby
Darren T. Beck
Nancy D. Merner
Extra-Virgin Olive Oil Enhances the Blood–Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial
Nutrients
Alzheimer’s disease
mild cognitive impairment
blood–brain barrier
contrast-enhanced MRI
functional MRI
extra-virgin olive oil
title Extra-Virgin Olive Oil Enhances the Blood–Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial
title_full Extra-Virgin Olive Oil Enhances the Blood–Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial
title_fullStr Extra-Virgin Olive Oil Enhances the Blood–Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial
title_full_unstemmed Extra-Virgin Olive Oil Enhances the Blood–Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial
title_short Extra-Virgin Olive Oil Enhances the Blood–Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial
title_sort extra virgin olive oil enhances the blood brain barrier function in mild cognitive impairment a randomized controlled trial
topic Alzheimer’s disease
mild cognitive impairment
blood–brain barrier
contrast-enhanced MRI
functional MRI
extra-virgin olive oil
url https://www.mdpi.com/2072-6643/14/23/5102
work_keys_str_mv AT amalkaddoumi extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT thomassdenney extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT gopikrishnadeshpande extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT jenniferlrobinson extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT ronaldjbeyers extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT davidtredden extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT domenicopratico extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT tassosckyriakides extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT bonianlu extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT annankirby extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT darrentbeck extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial
AT nancydmerner extravirginoliveoilenhancesthebloodbrainbarrierfunctioninmildcognitiveimpairmentarandomizedcontrolledtrial